BMO Capital analyst, Alex Arfaei, reiterated his Market Perform rating on shares of Eli Lilly (NYSE: LLY) but grudgingly raised ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE